I agree that this site is using cookies. You can find further informations here.
X
Pemmaraju, Naveen
590  results:
Search for persons X
?
1

Myeloproliferative neoplasms in the adolescent and young ad..:

Goulart, Hannah ; Masarova, Lucia ; Mesa, Ruben...
British Journal of Haematology.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

Prospective performance of the IWG-2023 criteria and IPSS-M..:

Urrutia, Samuel ; Bose, Prithviraj ; Alvarado, Yesid...
Blood Neoplasia.  1 (2024)  2 - p. 100008 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Overcoming Tagraxofusp-Erzs Monotherapy Resistance in Blast..:

Dhakal, Prajwal ; Sy, Mario ; Sutamtewagul, Grerk...
Journal of Immunotherapy and Precision Oncology.  , 2024
Link: https://doi.org/10.36401..
 
?
4

Efficacy and manageable safety of tagraxofusp in blastic pl..:

Pemmaraju, Naveen ; Cuglievan, Branko ; Lasky, Joseph...
eJHaem.  5 (2024)  1 - p. 61-69 , 2024
Link: https://doi.org/10.1002/..
 
?
5

Pivekimab sunirine (IMGN632), a novel CD123-targeting antib..:

Daver, Naval G ; Montesinos, Pau ; DeAngelo, Daniel J...
The Lancet Oncology.  25 (2024)  3 - p. 388-399 , 2024
Link: https://doi.org/10.1016/..
 
?
6

CD38 and BCL2 expression guides treatment with daratumumab ..:

Hu, Xiaoyi ; Ediriwickrema, Asiri ; Saleem, Atif...
Leukemia Research.  139 (2024)  - p. 107479 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Prognostic risk signature in patients with acute myeloid le..:

Bataller, Alex ; Bazinet, Alexandre ; DiNardo, Courtney D....
Blood Advances.  8 (2024)  4 - p. 927-935 , 2024
Link: https://doi.org/10.1182/..
 
?
8

Detection of PNH Clones can Aid in the Distinction of Aplas..:

Nasnas, Patrice ; Ling, Jianhua ; Gerstein, Yoheved...
Clinical Lymphoma Myeloma and Leukemia.  , 2024
Link: https://doi.org/10.1016/..
 
?
9

Reduced dose azacitidine plus venetoclax as maintenance the..:

Bazinet, Alexandre ; Kantarjian, Hagop ; Bataller, Alex...
The Lancet Haematology.  11 (2024)  4 - p. e287-e298 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Tagraxofusp, a first‐in‐class CD123‐targeted agent: Five‐ye..:

Jen, Wei‐Ying ; Konopleva, Marina ; Pemmaraju, Naveen
Cancer.  130 (2024)  13 - p. 2260-2271 , 2024
Link: https://doi.org/10.1002/..
 
?
11

Sotatercept for anemia of myelofibrosis: a phase II investi..:

Bose, Prithviraj ; Masarova, Lucia ; Pemmaraju, Naveen...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
12

Treatment of patients with blastic plasmacytoid dendritic c..:

Pemmaraju, Naveen ; Madanat, Yazan F. ; Rizzieri, David...
Leukemia & Lymphoma.  65 (2024)  5 - p. 548-559 , 2024
Link: https://doi.org/10.1080/..
 
?
13

A phase 1/2 study of mini-hyper-CVD plus venetoclax in pati..:

Short, Nicholas J. ; Jabbour, Elias ; Jain, Nitin...
Blood Advances.  8 (2024)  4 - p. 909-915 , 2024
Link: https://doi.org/10.1182/..
 
?
14

Targetable genetic abnormalities in patients with acute mye..:

Bataller, Alex ; DiNardo, Courtney D. ; Bazinet, Alexandre...
American Journal of Hematology.  99 (2024)  4 - p. 792-796 , 2024
Link: https://doi.org/10.1002/..
 
?
15

Phase 1b trial of tagraxofusp in combination with azacitidi..:

Lane, Andrew A. ; Garcia, Jacqueline S. ; Raulston, Evangeline G....
Blood Advances.  8 (2024)  3 - p. 591-602 , 2024
Link: https://doi.org/10.1182/..
 
1-15